MedPath

HCV, HBV, HIV Testing During Consultation With Anesthesiologist

Not Applicable
Terminated
Conditions
HBV
Hiv
HCV
Interventions
Procedure: HCV, HBV, HIV tests
Registration Number
NCT04286347
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of the study is to assess the feasibility of HCV, HBV, HIV testing (according to the national guidelines) during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France. The feasibility will be the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus).

Detailed Description

The aim of the study is to assess the feasibility of HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France.

The national guidelines recommend at least one HIV testing during life and, more recently, one HCV testing during life to eradicate HCV infection. HBV testing is recommended in patients coming from high prevalence countries, IVDU, prisoners, patients with multiple sexual partners.

The feasibility will be the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus).

HIV testing will use finger-stick whole blood (FSB) INSTI® HIV-1 \& HIV-2 Rapid Antibody Test FSB (BioLytical TM Laboratories Inc., Richmond, B.C., Canada), with a sensitivity 99% \[96.3-99.7\] and a specificity 99.3%.

HCV testing will use finger-stick whole blood (FSB) Oraquick® HCV test, with a sensitivity and a specificity 99.1 and 100% respectively.

HBV testing will use finger-stick whole blood (FSB) Vikia® HBs Ag test, bioMérieux with a sensitivity and a specificity 96.5 and 99.9% respectively.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
363
Inclusion Criteria
  • patient ≥ 18 years-old
  • planned surgery in Lariboisiere Hospital, Paris, France
  • able to give written informed consent for testing
  • proposed to be tested for HIV and HCV if no previous testing found in the medical record
  • proposed to be tested for HBV if the patient belong to a high-risk group: high prevalence area (Asia, sub-Saharan Africa, French Indies, East and South Europe, North-Africa, Middle-East, India, Pakistan, South-America), IVDU, prisoners, unprotected sexual intercourses.
Exclusion Criteria
  • patient < 18 years-old
  • emergency surgery
  • unable to give written informed consent for testing: psychiatric diseases, neurologic diseases, ...
  • a previous testing for HIV and HCV found in the medical record and no obvious risk factor after previous testing
  • the patient does not belong to a high-risk group for HBV

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HCV, HBV, HIV testingHCV, HBV, HIV testsAll patient ≥ 18 years-old with a next planned surgery in Lariboisiere Hospital, Paris, France, able to give written informed consent for testing will be proposed to be tested for HIV and HCV if no previous testing found in the medical record and will be proposed to be tested for HBV if the patient belong to a high-risk group: high prevalence area (Asia, sub-Saharan Africa, French Indies, East and South Europe, North-Africa, Middle-East, India, Pakistan, South-America), IVDU, prisoners, unprotected sexual intercourses.
Primary Outcome Measures
NameTimeMethod
Feasibility of HCV, HBV, HIV testingDay 0 : during initial consultation, up to 1 hour

Feasibility (assessed by the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus)) of HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France

Secondary Outcome Measures
NameTimeMethod
Acceptability of HCV, HBV, HIV testingDay 0 : during initial consultation, up to 1 hour

Acceptability (number of patients who accept to be tested divided by the number of patients who should have been tested according to the national guidelines (for each virus) of HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France

Acceptability of being treated (for each virus) for the patients who have been tested positive for HCV and/or HBV and/or HIV, by questionningduring Day 0, after the initial consultation

Acceptability of being treated (for each virus) for the patients who have been tested positive for HCV and/or HBV and/or HIV during consultation, by direct questionning, with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France.

Trial Locations

Locations (1)

Lariboisière

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath